In the news release, “(Musée Platinum Tokyo Launches DUO Hydrogen Treatment Across All Salons in Singapore)”, issued on (December 18 2025) by Musée Platinum Tokyo over PR Newswire, we are advised by the company that all mentions of “Musée Platinum Tokyo” should read “Musee Platinum Tokyo” rather than “Musée Platinum Tokyo” as originally issued inadvertently. Complete, corrected release follows:

Musee Platinum Tokyo Launches DUO Hydrogen Treatment Across All Salons in Singapore

SINGAPORE, Dec. 18, 2025 /PRNewswire/ — Musee Platinum Tokyo, a leading beauty brand with over 15 years in Singapore, has officially launched the DUO Hydrogen Treatment at all its salon locations. The non-invasive treatment is formulated for individuals with sensitive, acne-prone, eczema-prone, or reactive skin and is suitable for application to the face, scalp, and body, including delicate areas.

The hydrogen treatment offers a gentle, restorative approach to skincare, helping to calm irritation, support hydration, and enhance skin resilience. It is recommended for individuals experiencing redness, dryness, or sensitivity triggered by environmental stressors or Singapore’s humid climate.

The launch responds to growing demand among individuals in Singapore for effective yet gentle treatments that support deeper skin recovery and long-term skin resilience. The technology is designed to complement existing aesthetic services, including body hair removal, with a particular focus on improving skin health.

“We have observed an increase in individuals seeking solutions that address both visible skin concerns and underlying sensitivity,” said Karen, Operation Officer of Musee Platinum Tokyo. “The DUO Hydrogen Treatment allows us to offer a safe, non-invasive option that supports skin recovery without causing additional irritation.”

Technology Overview: Combining Hydrogen and Ozone-Based Therapies

DUO Hydrogen utilises two complementary technologies, Hydrogen Care and Ozone Care, to cleanse, soothe, and support skin that is compromised. During the Hydrogen Care stage, purified water is transformed into high-concentration hydrogen (3000PPB), which penetrates deep into the pores to neutralise free radicals and remove debris that contributes to inflammation and skin ageing.

Ozone Care enhances the treatment by delivering oxygen-rich ozone water using water plasma technology. This activates skin cells, reduces bacterial buildup, and promotes wound healing. Together, these components form a dual-action system that supports hydration, barrier repair, and clarity, qualities associated with advanced skin repair treatments.

Service Expansion and Safety Considerations

The treatment is now available at all Musee Platinum Tokyo locations in Singapore. To ensure safe application, all beauticians have completed advanced training in managing sensitive and eczema-prone skin. The treatment is fragrance-free and painless, aligning with the brand’s positioning as a provider of painless hair removal and non-invasive beauty services in Singapore.

Beauticians are trained to customise each session based on individual skin types and conditions. For individuals with active flare-ups or highly reactive skin, adjustments are made to treatment duration and application intensity. The process is designed to avoid common irritants typically found in traditional facials, making it suitable for both pre-treatment and post-treatment care.

Target Audience and Skin Benefits

Although the DUO Hydrogen Treatment was developed with eczema-prone individuals in mind, it is suitable for a broad range of skin types. Individuals with acne-prone, dry, oily, or reactive skin may benefit from regular sessions, typically recommended once every two to three weeks. For more active conditions, weekly sessions may be advised during the initial phase.

With consistent use, the treatment may help to:

• Reduce redness, irritation, and flare-ups
• Improve skin hydration and strengthen the barrier
• Smooth texture and support overall skin health
• Maintain resilient, comfortable skin across the face, scalp, and body

These benefits are particularly relevant for individuals seeking to manage chronic sensitivity while continuing with aesthetic treatments such as targeted skin therapy or hair removal.

Promotional Launch Offers

To mark the launch, Musee Platinum Tokyo is offering a limited-time trial of the DUO Hydrogen Treatment at $65 (regular price: $127.50). The introductory offer allows interested parties to experience the treatment and assess its suitability for their skin needs. Further details and booking information are available on their website.

About Musee Platinum Tokyo

With six salons across Singapore and over 15 years of beauty experience, Musee Platinum Tokyo is known for painless hair removal and advanced skincare treatments. The brand combines expertise with innovative solutions, emphasising safety, comfort, and non-invasive care across all services.

For more information or to book, visit www.musee-sg.com/en or follow @museeplatinum_sg on Instagram.

PARIS, Dec. 23, 2025 /PRNewswire/ — BOE recently participated in two signature UNESCO events in Paris and Namibia, demonstrating its leading-edge concepts and ecosystem building capacity in global science governance and STEM education innovation. BOE is the first Chinese technology company to endorse the United Nations International Decade of Sciences for Sustainable Development, 2024-2033.

Dialogue in Paris: contributing foresight on global science governance

As the sole industry representative from China, Si Da, Vice President and Chief Brand Officer of BOE, spoke at the Futures Workshop themed “Shaping the Futures of Science: The role of the International Decade of Sciences for Sustainable Development, 2024-2033,” a parallel session of World Futures Day at UNESCO’s Headquarters in Paris on December 2. This session focused on reimagining the impact of science over the next 25 years and the pivotal role of the International Decade in shaping the future of science. It was widely agreed among participants that the key to scientific advances lies in translating long-term vision into sustainable strategies and actions.

Si Da pointed out that to achieve the objectives of the International Decade, it is essential to “turn foresight into long-term, sustainable strategic investment and embed corporate social responsibility into an organization’s innovation DNA.” BOE is building an integrated sustainability framework of “organization, strategy, and brand.” Its sustainability practices range from conducting educational charity initiatives to building net-zero factories to leveraging digital technology to support cultural preservation.

Initiative in Namibia: supporting UNESCO Science Clubs Network to catalyze innovation across Africa

Following the “Windows to STEM” initiative in Kenya, BOE and UNESCO are taking cooperation further. On December 5, BOE supported UNESCO in the launch of the African science clubs participating in the UNESCO Science Clubs Network in Namibia. The goal is to connect science clubs across Africa to create an open, collaborative innovation community that shares resources, thus continually inspiring younger generations to explore science. This is a key practice in advancing the International Decade’s goal of inclusive science.

In an effort to boost regional vitality, BOE is partnering with UNESCO to launch the Science Club Challenge 2026. As the initiative’s exclusive sponsor, BOE will provide winners with smart learning devices such as tablets powered by its green technology. These efforts demonstrate BOE’s steadfast support for Africa’s innovation ecosystem as a longstanding partner, and also vividly embody the concept of its sustainability brand “Open Next Earth” (ONE).

From the dialogue in Paris to ecosystem building in Africa, BOE illustrates a clear pathway to global sustainable engagement as a tech company – contributing foresight to global governance while empowering regional innovation through concrete action. BOE remains committed to working alongside UNESCO and other global partners to build a more inclusive and sustainable future.

Exciting Announcement Right Before Christmas

MELBOURNE, Australia, Dec. 23, 2025 /PRNewswire/ — Fox ESS, a leading renewable energy solution provider, is thrilled to announce its partnership with five-time Olympic Champion Ian Thorpe as the company’s brand ambassador in Australia, just in time for Christmas. This collaboration represents a significant milestone for Fox ESS, aligning Ian’s values of excellence with the brand’s commitment to delivering reliable renewable energy solutions to homes and businesses across Australia.

Ian Thorpe is known for being a passionate environmental advocate and philanthropist, encouraging environmentally responsible behaviour among Australians. His commitment to green initiatives, such as using renewable energy, aligns perfectly with Fox ESS’s mission to eliminate barriers between families and access to clean, independent energy. Ian’s name evokes agility, performance, and trust—qualities that reflect Fox ESS’s dedication:

• Lighter: Continuously innovating to offer lighter products for effortless installation.
• Quicker: With a local service team ensuring rapid response times and modular product designs for faster set-ups.
• Higher: Delivering higher performance, efficiency, and trust.

“Every time I jump into the water, I know that swimming faster isn’t easy,” said Ian Thorpe, Olympic Champion and Fox ESS Brand Ambassador. “I’ve always believed in pushing boundaries and striving for excellence, both in sports and in life. That same mindset applies to our journey towards sustainable living for the sake of our planet. Australia is leading the way in the clean energy transition, and together with Fox ESS, we can embrace a greener, more efficient lifestyle.”

In 2025, Fox ESS was recognised as the number one residential energy storage provider in Europe by S&P Global Energy. As the brand rapidly grow in the Australian market, they focused on maximising the benefits of local initiatives like the Cheaper Home Batteries Program. Ian Thorpe as their ambassador reflects their ambition to champion the clean energy sector in the region.

Michael Zhu, CEO of Fox ESS, stated: “Ian Thorpe is a true legend—his career has redefined speed, performance, and resilience on the world stage. Our people are our greatest strength, and we’re honoured to welcome Ian to the Fox ESS family. Together, we look forward to helping Australians live better with independent, clean energy solutions that pave the way for a more sustainable future.”

With Ian Thorpe on board, Fox ESS is set to share inspiring stories and practical insights, helping Australians unlock the full benefits of advanced clean energy solutions. Stay tuned for more exciting content in 2026.

For more information, please visit: https://au.fox-ess.com

About Fox ESS
Founded in 2019 and headquartered in Wenzhou, China, Fox ESS is a national high-tech enterprise specializing in the R&D, production, sales, and service of renewable energy power equipment, with a strong focus on advanced power electronics. Committed to global growth, Fox ESS is on track to establish a presence in 70+ countries and regions by the end of 2025, and over 200 partnerships driving innovation across Asia, Europe, the Americas, Africa, and Oceania. Guided by a customer-first philosophy, we deliver high-efficiency renewable energy solutions worldwide through innovation and exceptional value.

DONGGUAN, China, Dec. 23, 2025 /PRNewswire/ — Fapon Biopharma, a biotech in developing therapeutic biologics including cytokine-antibody fusion proteins and T-cell engagers, announced the publication of pioneering research on FP008, a novel fusion protein in Cell Reports Medicine. The peer-reviewed article details the preclinical and translational validation of FP008 (anti-PD-1 × IL-10M). This first-in-class bifunctional fusion protein is designed to address a fundamental limitation in cancer immunotherapy: the inability to reactivate terminally exhausted T cells within tumors.

Interleukin-10 (IL-10) has shown potential to directly activate and expand exhausted CD8⁺ T cells, but its clinical application has been constrained by dose-limiting hematological toxicities. Fapon’s research team addressed this limitation by engineering IL-10 into a monomeric form (IL-10M). As reported, the engineered IL-10M demonstrated a significant reduction in toxicity. The innovative “cis-delivery” mechanism enabled targeted enrichment of IL-10M onto PD-1-positive exhausted CD8⁺ T cells within the tumor micro-environment. This approach mitigates systemic toxicity while potentially enhancing anti-tumor immune responses.

The study demonstrated FP008’s robust anti-tumor activity across multiple mouse tumor models, including those resistant to anti-PD-1 therapy. FP008 reversed terminal exhaustion of CD8⁺ T cells and restored their functional capacity through localized activation, minimizing systemic exposure.

In comprehensive GLP toxicology studies in cynomolgus monkeys, FP008 exhibited a favorable safety profile at doses up to 10 mg/kg, with no significant hematological adverse events observed. The data supported that this approach has the potential to overcome prior clinical limitations of IL-10-based therapies.

FP008 has cleared an Investigational New Drug (IND) application with the U.S. FDA and China NMPA. Phase I clinical trial is currently ongoing with readout expected later this year. FP008 represents a novel therapeutic strategy for patients with advanced solid tumors refractory to or relapsed from PD-1/PD-L1 checkpoint inhibitors.

Reference: Gu et al., Cell Reports Medicine(2025). “An innovative engineered IL-10 monomer strengthens T cell-mediated anti-tumor responses through anti-PD-1 cis-delivery.” DOI: doi.org/10.1016/j.xcrm.2025.102515 

-END-

About Fapon Biopharma

Fapon Biopharma specializes in discovering and developing biologics for cancer treatment, autoimmune diseases and other diseases where there are unmet medical needs. Leveraging cutting-edge technologies, we have built advanced drug discovery platforms, including an antibody discovery platform based on the globally leading mammalian cell display technology, a platform for generating IL-10M fusion proteins, a TCE platform based on cross-species CD3 nanobody of human and monkey. With a differentiated pipeline of leading drug candidates, we have established capabilities that cover the entire drug development process from drug discovery, preclinical research, Chemistry, Manufacturing and Controls (CMC) to early clinical development. Committed to innovation, we strive to deliver safer, more efficacious, affordable, and accessible biologics for everyone.

For more information about FP008 and partnership opportunities, please visit our website (https://en.faponbiopharma.com/) or contact our Business Development team at BiopharmaBD@fapon.com